Antibiotic Resistance in Streptococcus pneumoniae after Azithromycin Distribution for Trachoma
Trachoma is caused by Chlamydia trachomatis and is a leading cause of blindness worldwide. Mass distribution of azithromycin (AZM) is part of the strategy for the global elimination of blinding trachoma by 2020. Although resistance to AZM in C. trachomatis has not been reported, there have been conc...
Main Authors: | Derek K-H. Ho, Christian Sawicki, Nicholas Grassly |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Journal of Tropical Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/917370 |
Similar Items
-
Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
by: Kevin Cyrus Hong, et al.
Published: (2009-07-01) -
Azithromycin combination therapy increased emergence of antibiotic resistant Streptococcus pneumoniae in elderly patients hospitalized with pneumonia
by: Y. Mutoh, et al.
Published: (2020-02-01) -
Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
by: Abdou Amza, et al.
Published: (2021-01-01) -
Targeting antibiotics to households for trachoma control.
by: Isobel M Blake, et al.
Published: (2010-11-01) -
Mass treatment with azithromycin for trachoma control: participation clusters in households.
by: Elizabeth N Ssemanda, et al.
Published: (2010-10-01)